<DOC>
	<DOCNO>NCT02655042</DOCNO>
	<brief_summary>The primary purpose study ass long-term safety profile RCT-01 injection compare placebo injection . This study also measure long-term impact injection tendon structure function symptom Achilles tendinosis . This study design follow participant complete participation clinical trial receive injection either RCT-01 placebo Achilles tendon . No clinical intervention perform part study procedure . The day study entry ( Visit 1 ) coordinate participant 's final visit earlier clinical trial . All participant return clinic repeat assessment Achilles tendinosis overall health 6 , 12 18 month study entry . Furthermore , complete 'telephone visit ' ; report information overall health ; 3 , 9 , 15 month study entry . Total duration patient participation approximately 18 month .</brief_summary>
	<brief_title>Long-Term Follow-up Safety Efficacy RCT-01 Men Women With Unilateral , Chronic Achilles Tendinosis</brief_title>
	<detailed_description />
	<mesh_term>Tendinopathy</mesh_term>
	<criteria>Participation clinical trial design evaluate RCT01 treatment chronic Achilles tendinosis . Participants must complete final study visit earlier trial prior participation clinical trial . Willingness provide write informed consent participation study , attend study visit complete procedure require protocol . The presence condition , investigator 's opinion would impact participant safety and/or participant 's ability complete study related procedure . ( e.g. , psychiatric illness , drug addiction , alcoholism , etc . ) NOTE : age limit specifically set trial entry current trial base qualification/completion previous clinical trial age rage participant explicitly state .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>